• Protease Inhibitor Cocktail EDTA-Free: Safeguarding Signalin

  2026-05-26

  Discover how the Protease Inhibitor Cocktail EDTA-Free enables uncompromised protein extraction for phosphorylation analysis and neurogenetic research. This article explores its scientific advantages in preserving signaling pathways during advanced molecular biology workflows.

• Multi-omics Analysis Reveals ARID1A-Driven Resistance in Mel

  2026-05-26

  This study delivers a detailed systems biology analysis of melanoma drug resistance, focusing on ARID1A-dependent mechanisms that undermine BRAF/MAPK inhibitor efficacy. By integrating multi-omics data, the authors uncover key resistance nodes and potential therapeutic targets, providing new directions for overcoming adaptive resistance in metastatic melanoma.

• Exemestane: Steroidal Aromatase Inhibitor for Breast Cancer

  2026-05-25

  Exemestane delivers selective, irreversible aromatase inhibition for precise manipulation of estrogen biosynthesis in hormone-dependent cancer models. This guide details experimental workflows, troubleshooting strategies, and translational insights to maximize research outcomes with APExBIO's Exemestane (SKU: A1296).

• Amyloid Beta-peptide (25-35): Core Model for Neurotoxicity

  2026-05-25

  Amyloid Beta-peptide (25-35) (Aβ25-35) is a validated neurotoxic model for Alzheimer's disease research. It robustly induces microglial pro-inflammatory polarization, mitochondrial dysfunction, and amyloid aggregation, facilitating reproducible study of neurodegenerative mechanisms.

• Refining In Vitro Assessment of Drug Responses in Cancer Res

  2026-05-24

  Schwartz's 2022 dissertation presents a nuanced evaluation of in vitro drug response metrics in cancer, distinguishing between cell proliferation arrest and cell death. This approach clarifies drug efficacy interpretation and has practical implications for designing more informative preclinical assays.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody: Precision Tools for

  2026-05-23

  Explore how the HRP Rabbit Anti-Goat IgG (H+L) Antibody empowers advanced immunodetection of goat primary antibodies, with a focus on optimizing protocols for pulmonary fibrosis research. Discover unique assay strategies and scientific insights not found in existing articles.

• Aldosterone and Liddle Mutation Shape ENaC Processing in Mou

  2026-05-22

  This study dissects how aldosterone and a Liddle syndrome-mimicking mutation interact to control the proteolytic processing of the epithelial sodium channel (ENaC) in mouse kidneys. By using quantitative Western blot methods, the authors clarify how hormone signaling and genetic mutation converge on ENaC cleavage, with important implications for sodium homeostasis and hypertension.

• Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Technica

  2026-05-22

  The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) is engineered to protect protein samples from proteolytic and phosphatase activity during extraction, particularly in workflows requiring mass spectrometry compatibility. It is not suitable for protocols targeting metalloproteinase inhibition unless EDTA is added separately, nor for workflows utilizing non-aqueous solvents.

• EGCG in Translational Research: Mechanistic Leverage for IVD

  2026-05-21

  This article explores the multifaceted roles of (-)-Epigallocatechin gallate (EGCG) in modulating inflammation, apoptosis, and extracellular matrix stability, with a strategic focus on intervertebral disc degeneration (IVDD). Drawing from recent hydrogel-based delivery innovations and robust mechanistic data, we guide translational researchers in optimizing EGCG experimental protocols and highlight its competitive advantages, translational maturity, and evolving clinical relevance.

• Toremifene in Breast Cancer: 20 Years of Clinical Insights

  2026-05-21

  This review synthesizes two decades of data on toremifene, a selective estrogen receptor modulator (SERM), for breast cancer management. It highlights the evolution of endocrine therapy, the importance of biomarker-driven treatment, and comparative outcomes with aromatase inhibitors, providing a foundation for ongoing translational research.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetics

  2026-05-20

  This study introduces a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids with mature drug-metabolizing properties. The findings provide a robust in vitro platform for pharmacokinetic studies, addressing key limitations of animal models and traditional cell lines.

• Protease Inhibitor Cocktail EDTA-Free: Precision Protein Ext

  2026-05-20

  Unlock reproducible, phosphorylation-compatible protein analysis with APExBIO’s EDTA-free Protease Inhibitor Cocktail. Explore advanced troubleshooting, protocol optimization, and real-world use-cases for sensitive downstream workflows—especially where divalent cation integrity is essential.

• Polybrene (Hexadimethrine Bromide): Precision in Viral and D

  2026-05-19

  Polybrene (Hexadimethrine Bromide) 10 mg/mL elevates gene delivery by enhancing viral attachment and broadening cell transduction efficiency, especially for challenging cell lines. Explore actionable workflows, troubleshooting strategies, and the latest experimental insights that set APExBIO’s Polybrene apart in both routine and advanced molecular biology applications.

• Synergistic OXPHOS Disruption by LRPPRC Inhibitors and Dasat

  2026-05-19

  This study reveals that combining LRPPRC inhibition with dasatinib achieves a synergistic blockade of mitochondrial oxidative phosphorylation (OXPHOS) in cancer cells. By targeting both nuclear- and mitochondrial-encoded OXPHOS genes, this dual-genome strategy demonstrates enhanced anti-tumor efficacy and provides a mechanistic rationale for combination therapies in OXPHOS-dependent malignancies.

• DFCP1 Regulates ATGL-Driven Lipid Droplet Lipolysis in Starv

  2026-05-18

  This research clarifies how DFCP1 acts as a nutrient-sensitive regulator of lipid droplet catabolism by modulating the recruitment and retention of ATGL during cellular starvation. The findings offer a mechanistic advance in understanding lipid homeostasis and provide a foundation for more targeted research into metabolic disease mechanisms.

16696 records 1/1114 page Next 12345 下5页 Last page